HOPE Grows for Autism Archives - Green Market Report

StaffOctober 30, 2020
shutterstock_1012237351-1280x853.jpg

3min00

Zelira Therapeutics Ltd (ASX: ZLD, OTCQB: ZLDAF) just announced that its proprietary cannabinoid medicines, HOPE 1 and HOPE 2are now available by prescription to patients in Australia. The HOPE™ forumations, developed by Zelira and noted autism advocate Erica Daniels, first launched in 2019 in Pennsylvania and this fall in Louisiana. 

“We have had great success with HOPE™ in the US and are thrilled to be able to offer it to patients as a treatment option through the Therapeutic Goods Administration’s (TGA) Special Access Scheme,” says Osagie Imosogie, Chairman of Zelira Therapuetics. “Zelira is proud of this latest achievement in our mission to bring cannabinoid medicine to patients around the world.”

The HOPE cannabinoid medicines were developed to support the needs of patients with Autism Spectrum Disorder (ASD) by Daniels and Zelira Therapeutics, which then licensed the proprietary formulas to Ilera Healthcare in Pennsylvania and Ilera Holistic Healthcare in Louisiana. HOPE has since established itself as one of the top selling formulated medicinal cannabis products in Ilera Healthcare’s portfolio. 

“Autism families are finally beginning to have access to a truly better alternative than the harsh pharmaceuticals of the past and I am so proud that HOPE is now available in Australia,” says Erica Daniels, founder of Hope Grows for Autism and co-creator of the HOPE forumalations. “What started off as a labor of love to find a way to treat my own son is now helping parents around the world.” 

HOPE is part of Zelira’s family of revenue generating medicinal cannabis formulations. The products consist of two pharmaceutical-grade proprietary formulations developed as pharmaceutical-grade products targeting Autism Spectrum Disorder (ASD) as a disease indication. 

“Following the success of the HOPE™ launches in Pennsylvania and Louisiana, we are excited to make these products available to patients and physicians in Australia,” says Dr. Richard Hopkins, Zelira’s global Managing Director. “This represents another key milestone in our commitment to bring the benefits of HOPE to patients in global markets.”


StaffOctober 1, 2020
zelira.jpg

5min01

Launches First-in-the-State Medical Cannabis Product 

Scientifically Formulated for Autism Patients of All Ages

NEW ORLEANS (LA) October 1, 2020 /AxisWire/ Louisiana-based Ilera Holistic Healthcare is pleased to announce the statewide launch of the HOPE™ line of medical cannabis tinctures based on groundbreaking scientific research on using cannabis to treat the symptoms of autism spectrum disorder (ASD) in both children and adults.

Grown, cultivated, processed and packaged in Louisiana through a partnership between Ilera Holistic and Southern University’s Agricultural Center, HOPE™ products are available exclusively through state-licensed MMJ pharmacies and available to all Louisiana patients and families through a doctor’s prescription. 

“After seeing the success of HOPE™ in Pennsylvania, we were determined to bring it to patients of Louisiana, a state where we exceed the national percentage of autism diagnoses–while at-risk and under-served patients still struggle to receive safe and effective healthcare,” says Ilera Holistic CEO Dr. Chanda Macias. “Louisiana families deserve full access to all the benefits that cannabis medicine can provide, and we are thrilled to have HOPE in this market and available to everyone.”

Scientific research shows cannabis to be safe and effective on patients (including children) to treat ASD, and patients who use it have reported significant improvement in quality of life, mood, and sleep–and less reliance on other medications. 

HOPE™ is the brainchild of Erica Daniels, founder of Hope Grows for Autism, a nonprofit aimed at improving the lives of families affected by autism through research, education and advocacy of medical marijuana.

“The autism community in Louisiana is blessed to have a partner in Ilera Holistic Healthcare to bring HOPE to families affected by ASD,” says Daniels. “Now more than ever,  patients are struggling with the symptoms associated with autism. I am so thrilled that Ilera Holistic Healthcare is bringing HOPE to so many Louisiana patients who need it!”

“HOPE™ is another product with which we are proud to be associated,” said Janana Snowden, director of the Southern Institute for Medicinal Plants at the Southern University Agricultural Research and Extension Center. “The work we do aims to not only provide valuable research but to also provide potentially beneficial and accessible treatments for symptoms due to conditions that thousands of people live with daily, like autism.”

HOPE™ was formulated by Zelira Therapeutics, a leading global therapeutic medical cannabis company with access to the world’s largest and fastest growing cannabis markets. The company’s focus is on developing branded cannabis products for the treatment of a variety of medical conditions including insomnia, autism and chronic non-cancer pain.

HOPE™ is gluten, dairy, soy and nut-free; scientifically formulated, lab tested, and pesticide free; and only available in the state of Louisiana at licensed cannabis pharmacies. HOPE™ will be available in two formulations: “HOPE1,” a 1:1 THC:CBD tincture, and “HOPE2”, a 5:1 THC:CBD tincture. 

About Ilera Holistic Healthcare 

Ilera Holistic Healthcare is a fully integrated medical marijuana company that fuses science and innovation to discover life-changing therapies. In Louisiana, we partner our world-class cultivation and extraction methods with Southern University’s to expertly create and deliver consistent, high quality medicines. From seed and soil to dispensary shelves, Ilera is committed to providing a superior health and wellness experience. 

 

###

 


Julie AitchesonSeptember 30, 2020
Patient.jpg

5min01

Autism is a developmental disorder characterized by communication and behavioral difficulties from minor to extremely severe. There is no medical cure for autism and much remains mysterious about the condition. There is no blood test or similarly straightforward means of diagnosis, and can often be missed for years or even a lifetime by a physician.  Autism can express differently in every individual, with a broad range of symptoms and gradients of severity that can make treating symptoms even more challenging than gaining a diagnosis. Conventional treatments for symptoms of ASD, which include a variety of drugs to relieve seizures or behavioral and anxiety issues, often come with serious side effects of their own. While interventions like cognitive behavioral therapy and speech-language therapy can have a positive impact on outcomes for those with ASD, those with more severe conditions may require some form of medication. Yet again, the adverse side effects that come with these medications create an untenable Catch-22 for ASD patients and caregivers alike. Enter HOPE.

HOPE tinctures are the creation of Zelira Therapeutics and Erica Daniels, founder of Hope Grows for Autism, a nonprofit aimed at improving the lives of families affected by autism through research, education, and advocacy of natural treatments. Daniels is a proud partner of Zelira Therapeutics, which formed through a merger of Zelda and Ilera Therapeutics in 2019. As the mother of a child with severe autism, Daniels responded to years of traveling the country in an exhaustive but fruitless search for treatments for her son by forging her own path, using diet and medical cannabis to ensure a high quality of life for her son and family.

Through partnerships within the state of Louisiana, HOPE tinctures (which are specifically formulated with Autism Spectrum Disorder in mind) will be available exclusively through state-licensed medical marijuana dispensaries in the state to all patients and families bearing a doctor’s prescription. The tinctures will be available in two formulations, “HOPE1”, which is a 1:1 THC: CBD tincture, and “HOPE2”, a 5:1 THC: CBD tincture. 

Louisiana ranks higher than the national average for the percentage of autism diagnoses per capita and recently passed legislation in the state allows all Louisiana patients and families to receive medical cannabis through a doctor’s prescription for any condition. This makes it a perfect staging ground for this new partnership between the HOPE line of medical cannabis tinctures, Lousiana’s Ilera Holistic Healthcare, and Southern University’s Agricultural Center, through which the tinctures are grown, cultivated, processed, and packaged. With the introduction of the specially formulated and research-based HOPE tinctures into medical marijuana dispensaries across Louisiana, Erica Daniels is excited to bring the benefits of cannabis to other constituents in the ASD community.

HOPE™ was formulated by Zelira Therapeutics a leading global therapeutic medical cannabis company with access to the world’s largest and fastest growing cannabis markets. The company’s focus is on developing branded cannabis products for the treatment of a variety of medical conditions including insomnia, autism and chronic non-cancer pain.

 


Kaitlin DomangueJune 17, 2020
Screenshot-2020-06-17-at-1.25.58-PM.png

4min01

Zelira Therapeutics Ltd (OTCMKTS: ZLDAF) could be changing the way we approach autism. Zelira is a global therapeutic medicinal cannabis company headquartered in Australia. It works closely with leading researchers and organizations including Curtin University in Perth, Western Australia, the Telethon Kids Institute, the University of Western Australia, in Perth, St. Vincent’s Hospital in Melbourne, Australia, and the Children’s Hospital of Philadelphia (CHOP) in the United States.

Zelira is executing human clinical trials with medical marijuana, focusing on insomnia, opioid reduction, and autism. Subsequently, the company released a white paper detailing the survey results of 50 patients within the Hope Grows for Autism network in Pennsylvania. All of the patients used Ilera Healthcare’s HOPE product line. They were all residents of Pennsylvania and able to legally purchase medicinal cannabis. The findings were astounding.  

The white paper reads, “Respondents who used HOPE™ 1 tincture with a THC:CBD ratio of 1:1 with Eucalyptol, Valencene and Alpha-Pinene terpenes, HOPE™ 2 tincture with a THC:CBD ratio of 5:1 with beta-Caryophyllene, Myrcene and Alpha-Bisabolol terpenes or both products for a range of 5-133 days (average of 68 days of use) reported the following: Significant improvements in patient irritability (68%), meltdowns (60%), aggression (55%), anxiety (49%) as well as capacity to focus (38%); while 69% of participants reported an improved quality of life for the patient. In addition, 58% reported improved quality of life for the entire family.” In other words, a THC:CBD tincture of varying doses and a rich terpene profile produced significant improvements and quality of life for the patients. 26% of patients used only HOPE 1, 54% of patients used only HOPE 2, and 20% of patients used both HOPE 1 and HOPE 2. 

According to the data, 0% of patients reported the patient’s symptoms worsening. This is a great example of the cannabis plant’s gentle properties and minimal side effects. Additionally, less than 30% of participants reported no change in symptoms for anxiety, aggression, meltdowns, and irritability, with roughly 42% of participants reporting no change in the patient’s ability to focus. The majority of patients, however, noted significant improvement, with a small percentage noticing some improvement. 

The report acknowledges there are some limitations with the data. All of the survey responses were based on caregiver responses with no control group, nor did the survey collect information on the patient’s ASD history or associated symptoms. Nevertheless, “there is a strong and widely accepted belief that the main caregivers are the most reliable source of information to evaluate the status of a patient with ASD.”

“Our 5-year-old has been on HOPE™ for just over a year now, it has positively saved our lives!,” said a survey participant. “To think what our day-to-day was and what it is now is just remarkable… Within two weeks of Ilera HOPE™ the difference was night and day! Sleeping consistently, better appetite, better focus at school, much better overall behavior and mood.”

Dr. Richard Magill is the Medical Director at PA Green Med and said, “All physicians who treat patients with Autism Spectrum Disorder should be aware that HOPE™ represents a significant addition to the potential tools we have to improve the lives of ASD patients and their families.”


StaffMay 13, 2020
shutterstock_660308902-1280x796.jpg

9min02

Ever since recreational cannabis has stolen the stage, people tend to forget that cannabis is one of the oldest and most trusted medicines on the planet.

The medicinal properties within the plant are responsible for managing the symptoms associated in patients suffering from Epilepsy, Autism, Crohn’s Disease, Cancer, PTSD, and Chronic Pain to name just a few.

These brands have developed some of the best practices and formulations in the industry to treat a myriad of ailments with patents pending across the globe.

Our team decided to break down a list of the most respected medical brands and products within the cannabis industry globally.

Here they are:

 

1.) Charlotte’s Web:

More than just CBD: CBD plus naturally-occurring phytocannabinoids, terpenes, flavonoids and more in every CBD oil serving. The team from Charlotte’s Web uses limited, select ingredients to ensure you have the absolute best hemp extract possible. Their CBD oils include Charlotte’s Web premium hemp extract, carrier oil, and flavor. That’s it. Their products are U.S. Hemp Authority Certified. Charlotte’s Web CBD oils are whole-plant extracts that include a variety of of beneficial compounds, including phytocannabinoids, terpenes, flavonoids, and essential fatty acids.

 

2.) Aunt Zelda’s:

Aunt Zelda’s is a pioneering, data-driven developer of cannabis-based plant medicines. Our products are the result of years of research and development by founders, Mara Gordon and Stewart Smith, in consultation with knowledgeable physicians and world-renowned researchers.

Utilizing proven time-tested extraction processes improved with modern technology, Aunt Zelda’s offers medicines of precisely measured potency and purity that empower patients to dose to the milligram and unlock the therapeutic potential of cannabis.

If you prefer to obtain lab tested products created for specific ailments, Aunt Zelda’s will help you get there!

Aunt Zelda’s mission is to alleviate patient suffering through medical cannabis.  We help you, our patients, live fulfilling, healthy lives.

They provide unmatched expertise in the correct use of medical cannabis matched to disease-specific products with the highest purity in California.

Their goal is to create a positive and supportive community for medical cannabis users. They aspire to be your trusted source of cannabis resources and its safe, effective and responsible use

 

3.) HOPE Grows for Autism:

Formulation by: Zelira Therapeutics

HOPE is a Proprietary formulation specifically to address patient symptoms associated with Autism Spectrum Disorder.  The HOPE® Franchise has received support from organizations such as HOPE Grows for Autism, a leading autism advocacy group based in Pennsylvania. It has been the top performing product within the state and will soon be available for patients in Louisiana and throughout the US and Australia. 

In a company press release in December 2019, Zelira Therapeutics leadership said, “Our company will have the ability to distribute the HOPE® portfolio along with our additional products through licensing agreements with multi-state and international operators…”

HOPE 1 and HOPE 2 are part of a growing family of proprietary medical marijuana formulations. HOPE™ is created by extracting, isolating, and then re-assembling the medicinal compounds from the marijuana plant to achieve specific, targeted effects. HOPE™ was formulated with autism in mind and has quickly proved to be beneficial to other chronic conditions such as chronic pain, anxiety, neuropathy and others. HOPE™ has since become its manufacturer’s best-selling tincture.

 WHAT FORMS OF HOPE ARE AVAILABLE?

Available as a tincture, blended in 100% olive oil.

WHAT MAKES UP HOPE?

THC + CBD + Terpenes

Found in the trichomes of the plant, terpenes are plant oils with unique aromas and distinctive​ flavors (pine, citrus, mint) and are known to play​ a key role on the overall effects of each strain. ​ Terpenes also play a key role in differentiating​ the flavor and scent of marijuana. Some terpenes​ might promote relaxation, while others energy or​ focus.

 

4.) Ilera Holistic Healthcare:

ALAFIA — which means ‘inner peace’ in the Nigerian “Yoruba” language — is scientifically formulated, lab tested and pesticide free. Currently on the market are two formulated PURE CBD tinctures: Isolate CBD with 500mg and 1000mg  and Full Spectrum CBD with 500mg and 1000mg.  This product is Additional CBD products will be released at dispensaries in the state of Louisiana only.

“Our vision has always been patient access and affordability,” said Chanda Macias, chief executive officer of Ilera Holistic Healthcare. “It was imperative for us to bring high-quality products that support health and wellness.  Patients now have the ability to purchase ALAFIA over the counter without a prescription anywhere it is available.”  Dr. Chanda Macias said back in January 2020

5.) Haleigh’s Hope:

Extra strength has double the concentration than the regular strength, allowing the consumer to take less oil but still get the same desired therapeutic effect as the regular strength. Extra Strength products are recommended for people over 100 lbs.

This organically grown, whole plant extract contains a broad spectrum of naturally occurring plant based compounds that are clinically proven to provide a powerful combination of antioxidants and neuroprotectants. Haleigh’s Hope® was created from a proprietary genetic plant strain that was carefully bred and cultivated over seven years to achieve a precise combination of clinically proven, therapeutic plant compounds..

Haleigh’s Hope® grows, extracts, produces, packages and ships 100% of our product from our facilities in Colorado. Because we have exclusive control over our products from seed to sale, we ensure the highest levels of quality and consistency in the industry. Every batch of our product is lab tested for safety and quality.

Safflower is a cold pressed seed oil that is non-GMO and organic, and does not need to be shaken.

Exclusively grown and manufactured in Colorado, USA.


Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.